Clinical Trial Update: Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating vaccine therapy and monoclonal antibody therapy for stage IV melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma
• Melanoma

Drugs mentioned

• Monoclonal antibody therapy
• Vaccine therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 2 | Status: COMPLETED